Appeal No. 2005-0027
Application No. 09/777,874
and decreases ketone levels in the blood.” Col. 3, lines 60-65. Hastings (abstract) also
describes a method for inducing weight loss in a mammal by administering its L-
carnitine and hydroxycitrate composition. Thus, the combination of Hastings and
Wiegand reasonably appears to describe a method for facilitating the metabolism of
lipids.
Claim 26 is directed to a method for reducing food consumption comprising
administering to a subject in need thereof, an effective amount of the composition of
claim 11. Hastings describes at column 2, lines 35-40 that its composition curbs
appetite and reduces cravings. Thus, it would reasonably appear that the combination
of Hastings and Wiegand describes a method for reducing food consumption by curbing
appetite and reducing cravings.
Claim 27 is directed to a method for reducing body weight comprising
administering to a subject in need thereof, an effective amount of the composition of
claim 11. Hastings (abstract, column 1, lines 5-15) states that its described
composition helps facilitate weight loss. Thus, the combination of Hastings and
Wiegand would reasonably appear to describe a method of reducing body weight.
In view of the above, we affirm the rejection of claims 25-27 over Hastings in
view of Wiegand or Burtle.
9
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Last modified: November 3, 2007